Global law firm White & Case LLP has expanded its Global Intellectual Property Practice with the addition of Colleen Tracy James, a leading life sciences patent litigator, as a partner in New York.
"With pharmaceutical manufacturers seeing an uptick in patent litigation challenges, there is growing demand for our market-leading capabilities in this area," said Anita Varma, Head of White & Case's Global Intellectual Property Practice. "Colleen is a prominent first-chair IP litigator with deep experience leading clients through complex patent disputes in the life sciences industry. She will be instrumental in further expanding the Firm's practice as a preeminent adviser for litigation in the pharma, biotech and medtech sectors."
James represents companies in patent infringement litigation, USPTO Patent Trial and Appeal Board proceedings, and other complex intellectual property litigation in the life sciences industry. She has extensive experience litigating against generic pharmaceutical companies in matters brought under the Hatch-Waxman Act in federal district courts across the US and the Federal Circuit. She also provides advice on matters regarding freedom-to-operate opinions, licensing and due diligence.
"Following Peter Armenio's arrival in July, we're extremely pleased to welcome another leading, first-chair patent litigator to our team," said Jack Pace, Head of White & Case's Competition Section for the Americas. "Colleen has a track record of success both in and out of the courtroom, with strong client relationships that have clear synergies with our existing Intellectual Property Practice. Her arrival will add further bench strength to our patent capabilities, and allow us to continue delivering a high level of service in complex, strategic litigations."
James joins White & Case from Quinn Emanuel Urquhart & Sullivan. Her arrival follows the recent addition of Peter Armenio as a partner in the Firm's Intellectual Property Practice in July 2021.
Press contact
For more information please speak to your local media contact.
